Clinico-Spirometric Profile of Bronchiectasis Patients Presenting to Tertiary Care Centre, Dhiraj Hospital, Vadodara, Gujarat

Article Sidebar

PDF
Published: Jan 11, 2023
Keywords:
Bronchiectasis spirometry clinical profile

Main Article Content

Arti D. Shah
PROFESSOR & HEAD OF THE DEPARTMENT, DEPARTMENT OF RESPIRATORY MEDICINE, SBKS MI&RC, SUMANDEEP VIDYAPEETH DEEMED TO BE UNIVERSITY, VADODARA, GUJARAT, INDIA.
Mothiganesh.G
RESIDENT, DEPARTMENT OF RESPIRATORY MEDICINE, SBKS MI&RC, SUMANDEEP VIDYAPEETH DEEMED TO BE UNIVERSITY, VADODARA, GUJARAT, INDIA.
Chirag H. Chakravarti
ASSISTANT PROFESSOR, DEPARTMENT OF RESPIRATORY MEDICINE, SBKS MI&RC, SUMANDEEP VIDYAPEETH DEEMED TO BE UNIVERSITY, VADODARA, GUJARAT, INDIA.
Sonal Goyal
SENIOR RESIDENT, DEPARTMENT OF RESPIRATORY MEDICINE, SBKS MI&RC, SUMANDEEP VIDYAPEETH DEEMED TO BE UNIVERSITY, VADODARA, GUJARAT, INDIA.
Ujwal Jain
SENIOR RESIDENT, DEPARTMENT OF RESPIRATORY MEDICINE, SBKS MI&RC, SUMANDEEP VIDYAPEETH DEEMED TO BE UNIVERSITY, VADODARA, GUJARAT, INDIA.

Abstract

INTRODUCTION:


Bronchiectasis is a chronic, unrestrained dilatation of the subsegmental airways[1]. The bronchiectasis patient group is highly varied, with a range of diseases with various aetiologies and varying clinical, radiological, and microbiological features[2]. It is unknown how often bronchiectasis is. The condition is extremely understudied, especially in our region of the world[3]. High resolution CT (HRCT) scanning has evolved into the gold standard for bronchiectasis diagnosis[4]. To evaluate the functional impact of bronchiectasis-related deterioration, pulmonary function tests are employed. On a pulmonary function test, obstructive impairment (i.e., decreased FEV1, low FVC, and low FEV1/FVC ratio) is most often observed[5].For the same reason, we discover various and unique clinical profiles in BRONCHIECTASIS patients.


AIM: To build a clinico-spirometric profile of diagnosed BRONCHIECTASIS patients presenting to a tertiary health care centre in Vadodara.


METHODS: This observational cross sectional study was conducted at Respiratory Medicine department for total duration of 18 months.This study included 75 patients with bronchiectasis. Each patient had undergone a thorough evaluation of their history followed by clinical examination and spirometry.


RESULTS: There were 75 patients in total. 59% of the population, who were  men and were 48.84+/-15.470 years  of mean age, had never smoked. The most common symptom was cough with expectoration(82%) followed by dyspnea(60%) followed by chestpain(32%). The most frequent recognised cause of bronchiectasis was Post-TB. The respective mean values for FEV1, FVC, and FEV1/FVC were 51.58, 63.07, and 71.78. The pulmonary function test results for the 75 patients showed 12% with normal results, 21.33% with restrictive, 22.67% with mixed, and 44% with obstructive patterns. As compared to other patterns on spirometry, mixed type pulmonary function impairment was more commonly seen.


CONCLUSION:One of the main underlying disease processes that have been found in our area leading to bronchiectasis is Tuberculosis. Most patients presented with cough with expectoration followed by dyspnea. Patients with bronchiectasis in our region are observed to frequently have mixed pulmonary function abnormalities. 

Article Details

How to Cite
Arti D. Shah, Mothiganesh.G, Chirag H. Chakravarti, Sonal Goyal, & Ujwal Jain. (2023). Clinico-Spirometric Profile of Bronchiectasis Patients Presenting to Tertiary Care Centre, Dhiraj Hospital, Vadodara, Gujarat. Journal of Coastal Life Medicine, 11(1), 2017–2025. Retrieved from https://www.jclmm.com/index.php/journal/article/view/632
Issue
Vol. 11: Number 1, 2023
Section
Articles

References

Reid LM. Reduction in bronchial subdivision in bronchiectasis. Thorax. 1950 Sep;5(3):233.

Barker AF. Bronchiectasis. N Engl J Med 2002; 346: 1383–1393.

Frey JG. Bronchiectasis – a reemerging disease. Rev Med Suisse 2007; 3: 477-8.

Anne E, O’Donnell. Bronchiectasis. Chest 2008; 134:815-23.

Seaton D. Bronchiectasis. Anthony Seaton, Douglas Seaton A. Gordon Leitch. Crofton and Douglas’s respiratory disease. 5th ed. London: Blackwell Science;2000: p.808.

Cochrane GM. Chronic bronchial sepsis and progressive lung damage. BMJ 1985; 290: 1026–7.

Cole PJ. Inflammation a two edged sword: The model ofbronchiectasis. Eur J. Resp. Dis. 1986; 69 (Suppl. 147):6–15.

Stockley RA, Hill SL, Morrison HM, Starkice CM. Elas-tolytic activity of sputum and its relation to purulenceand to lung function in-patients with bronchiectasis.Thorax 1984; 39: 408–13.

Norman D, Elborn JS, Rayner R, Hiller EJ, Shale DJ.Tumour necrosis factor alpha in patients with cysticfibrosis. Thorax 1991; 46: 91–5.

Nicotra MB, Rivera M, Dale AM, Shepherd R, Carter R. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest. 1995 Oct;108(4):955-61. doi: 10.1378/chest.108.4.955. PMID: 7555168.

Utpat K, Nanaware S, Desai U, Joshi JM. Clinical profile and aetiology of bronchiectasis. Journal of Krishna Institute of Medical Sciences University. 2017 Oct 1;6:28-37.

Dimakou K, Triantafillidou C, Toumbis M, Tsikritsaki K, Malagari K, Bakakos P. Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Respiratory Medicine. 2016 Jul 1;116:1-7.

Alzeer AH, Masood M, Basha SJ, Shaik SA. Survival of bronchiectatic patients with respiratory failure in ICU. BMC pulmonary medicine. 2007 Dec;7:1-6.

Tiwari P, Resident J, Bhopal GMC. ORIGINAL RESEARCH PAPER SPIROMETRIC AND BACTERIOLOGICAL PROFILE IN Dr Nishant Srivastava Dr Krishna Kant Kawre. 2017;(12):82-5

Sundrarajaperumal A, Nedunchezhian R, Ranganathan D, Sundar V. Radiological and pulmonary function test assessment in clinically stable bronchiectasis patients.